About
Mark Kotter is a neurosurgeon, stem cell biologist, and entrepreneur associated with the University of Cambridge. He founded bit.bio, a synthetic biology company focused on programmable human cells for research, drug discovery, and cell therapy, and later became a board member/vice chairman. He is also publicly associated with Meatable as a co-founder, reflecting broader interests in synthetic biology and applied biotechnology.
Areas of interest
biotechsynthetic biologystem cellsregenerative medicinecell programmingdrug discoverycell therapylongevityrejuvenation biologyneurosciencecultivated meatsustainability